Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-19269

Infante, R M; Ericsson, C D; Jiang, Z D; Ke, S; Steffen, R; Riopel, L; Sack, D A; DuPont, H L (2004). Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy. Clinical Gastroenterology and Hepatology, 2(2):135-138.

[img] PDF - Registered users only
1MB

View at publisher

Abstract

BACKGROUND AND AIMS: We have recently shown that enteroaggregative Escherichia coli (EAEC) strains commonly cause travelers' diarrhea. The study was designed to determine whether U.S. travelers with EAEC diarrhea responded to rifaximin therapy. METHODS: In a multicenter placebo-controlled clinical trial of travelers' diarrhea without non-EAEC pathogens we evaluated 2 doses of rifaximin. EAEC was sought in stool samples in enrolled subjects by HEp-2 cell assay. Response to rifaximin (both groups combined) and placebo were evaluated in EAEC-positive and EAEC-negative patient groups. RESULTS: Compared with placebo, rifaximin shortened the postenrollment illness in travelers with EAEC diarrhea (median, 22 vs. 72 hours; P = 0.03). In subjects with EAEC-negative diarrhea, the median duration of post-treatment diarrhea was shorter with rifaximin (33 hours) than with placebo (52 hours), but this difference was not significantly different (P = 0.14). CONCLUSIONS: Improvement of EAEC-mediated diarrhea with antibiotic treatment supports the pathogenicity of this organism in travelers to developing countries. The study provides information on the value of the poorly absorbed drug rifaximin in therapy of travelers' diarrhea.

Citations

29 citations in Web of Science®
40 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 17 Jun 2009
0 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Epidemology, Biostatistics and Prevention Institute (EBPI)
DDC:610 Medicine & health
Language:English
Date:2004
Deposited On:17 Jun 2009 10:47
Last Modified:27 Nov 2013 19:06
Publisher:Elsevier
ISSN:1542-3565
Publisher DOI:10.1016/S1542-3565(03)00322-7
Official URL:http://linkinghub.elsevier.com/retrieve/pii/S1542356503003227
PubMed ID:15017618

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page